Results 251 to 260 of about 38,144 (289)
Some of the next articles are maybe not open access.
Drug and Alcohol Dependence, 2020
Co-located treatment for hepatitis C virus (HCV) infection for patients with opioid use disorder (OUD) within an opioid treatment program (OTP) addresses gaps in the HCV care continuum. Few reports have analyzed outcomes related to OUD treatment, such as retention, associated with co-located HCV treatment.Patients (n = 89) treated for OUD and chronic ...
Brooke, Severe +3 more
openaire +2 more sources
Co-located treatment for hepatitis C virus (HCV) infection for patients with opioid use disorder (OUD) within an opioid treatment program (OTP) addresses gaps in the HCV care continuum. Few reports have analyzed outcomes related to OUD treatment, such as retention, associated with co-located HCV treatment.Patients (n = 89) treated for OUD and chronic ...
Brooke, Severe +3 more
openaire +2 more sources
Innovations in agonist maintenance treatment of opioid-dependent patients
Current Opinion in Psychiatry, 2006To provide an overview of published studies on agonist maintenance treatment options for opioid-dependent patients.The recent publication of controlled trials confirms earlier clinical evidence of the efficacy of diamorphine (heroin) in the treatment of opioid dependence.
Haasen, Christian, van den Brink, Wim
openaire +3 more sources
INTERIM OPIOID AGONIST TREATMENT FOR OPIOID ADDICTION. A SYSTEMATIC REVIEW.
2019We plan to conduct a systematic review assessing the benefits of interim opioid agonist treatment in terms of retention in treatment, access to standard opioid agonist maintenance treatment, patient satisfaction, quality of life or wellbeing, use of psychoactive substances, criminal activities, mental and physical health status and adverse effects and ...
Solà, Ivan, Jofra, Laura Samsó
openaire +1 more source
Regulation of dynorphin gene expression by κ-opioid agonist treatment
Neuroreport, 2002The effects of K-opioid agonist treatment on prodynorphin mRNA expression in the rat brain were studied. Rats were treated with the selective kappa-opioid agonist U-69593 or vehicle for 5 days and prodynorphin mRNA was measured on day 8 (3 days after the last injection) or 22 (17 days after the last injection).
COLLINS S +4 more
openaire +3 more sources
Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist
NeuroReport, 1996Levels of mRNA coding for mu and delta opioid receptors were evaluated by competitive PCR in regions of rat brain where adaptive changes in opioid regulation of adenylyl cyclase occur following chronic morphine treatment. Correlation between receptor protein and mRNA levels after exposure to full and partial agonists were also investigated in NG108-15 ...
B, Buzas, J, Rosenberger, B M, Cox
openaire +2 more sources
Seminars in Neuroscience, 1997
Abstract After years of failures in managing heroin addiction by both supportive and punitive abstinence-based treatment modalities or incarceration, with or without initial short-term detoxification using an opioid agonist, research into the potential use of primarily mu opioid receptor directed agonist (or use of a partial agonist) in the chronic ...
openaire +1 more source
Abstract After years of failures in managing heroin addiction by both supportive and punitive abstinence-based treatment modalities or incarceration, with or without initial short-term detoxification using an opioid agonist, research into the potential use of primarily mu opioid receptor directed agonist (or use of a partial agonist) in the chronic ...
openaire +1 more source
Implementing Opioid Agonist Treatment in Correctional Facilities
JAMA Internal Medicine, 2018Kevin, Fiscella +2 more
openaire +2 more sources
A truly patient-centred evaluation of opioid agonist treatment
The Lancet Psychiatry, 2023Joan, Trujols +3 more
openaire +2 more sources
Opioid agonist treatment for self-harm and suicide prevention
The Lancet Psychiatry, 2022Paul S, Nestadt, Alison, Athey
openaire +2 more sources
The urgent need for opioid agonist treatment in Russia
The Lancet HIV, 2023Leah, Harvey +2 more
openaire +2 more sources